Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
New methods to reprogram adult cells could create novel models of disease.
Drugs in development could treat the cognitive deficits caused by Alzheimer’s.
A recently discovered cell survival switch could be key to increasing longevity.
Studying the club drug could bring about faster-acting and more-effective treatments.
New brain scanners could shed light on fear, joy, and disease.
Researchers hope that curcumin encapsulated in nanospheres will spice up clinical trials for Alzheimer’s, cystic fibrosis, and cancer.
A new imager that performs simultaneous MRI and PET scans could, among other applications, speed up the study of Alzheimer’s disease.
An ultrasensitive NMR probe could improve the diagnosis of diseases such as Alzheimer’s.
A compound that helps memory recall in brain-damaged mice could pave the way for new drugs to treat dementia.
Newly discovered variants in a key gene may indicate a modest risk for late-onset Alzheimer’s disease.